Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,169
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
for
Multiple Myeloma
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Sex: All
Age: 18+
Code: NCT05530096
Recruiting
Hypotension Prediction Index in Postoperative Surgical Patients
for
Surgery
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Sex: All
Age: 45+
Code: NCT05335174
Recruiting
Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Montreal
Sponsor: McGill University
Sex: Female
Age: 19 - 65
Code: NCT00764972
Phase 1, Phase 2, Recruiting
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
for
Solid Tumors
Location: Montreal, Boston MA, Toronto, Durham NC, Saint Paul MN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT05203172
Phase 4, Recruiting
GRID Therapy as Palliative Radiation for Patients With Advanced and Symptomatic Tumors
for
Patients With Symptomatic or Bulky Tumors (More Than 8 cm) or With Tumors Resistant to Radiation,
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Sex: All
Age: 18+
Code: NCT02333110
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis
for
Infective Endocarditis, Native Valve Endocarditis
Location: Montreal
Sponsor: Montreal Heart Institute
Sex: All
Age: 18+
Code: NCT04792281
Recruiting
Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy
for
Prostate Cancer, Erectile Dysfunction
Location: Montreal
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Sex: Male
Age: 18+
Code: NCT06521710
Recruiting
Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU
for
Family Members, Recruitment, Clinical Study, Retention,
Location: Montreal
Sponsor: Lady Davis Institute
Sex: All
Age: 18+
Code: NCT06588101
Recruiting
A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer
for
Pancreatic Cancer
Location: Montreal
Sponsor: Petr Kavan
Sex: All
Age: 18+
Code: NCT03167112
Phase 2, Recruiting
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
for
Non-Small Cell Lung Cancer
Location: Montreal, Ottawa, New Haven CT, The Bronx NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05789082
Phase 1, Phase 2, Recruiting
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
for
Non-Small Cell Lung Cancer
Location: Montreal, Winchester VA, St Louis MO, Palm Bay FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07680790
Phase 3, Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Montreal, Sherbrooke, Quebec, Boston MA, New York NY,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
for
Colorectal Cancer
Location: Montreal, Ottawa, Toronto, Philadelphia PA, Columbus OH,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT06948448
Phase 2, Recruiting
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
for
Neoplasm Malignant
Location: Montreal, Ottawa, New Brunswick NJ, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07209111
Phase 2, Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
for
Castration-Resistant Prostatic Cancer, Metastasis
Location: Montreal, Sherbrooke, Toronto, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06863272
Phase 1, Phase 2, Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue